[1] 李姜惠子, 刘洋, 王秀娟, 等. sPD-1/sPD-L1与Th1/Th2及Th17/Treg相关细胞因子在原发免疫性血小板减少症中的研究[J]. 中国免疫学杂志, 2019, 35(4): 467. doi: 10.3969/j.issn.1000-484X.2019.04.016
[2] 陈洋, 闫薛, 张婷, 等. 激素无效型免疫性血小板减少症患者T淋巴细胞亚群与血小板特异性自身抗体的相关性分析[J]. 临床血液学杂志, 2021, 34(11): 807. doi: 10.13201/j.issn.1004-2806.2021.11.012
[3] 吴小乐, 刘欢乐, 郑周, 等. 血小板参数在鉴别诊断免疫性血小板减少症和再生障碍性贫血中的作用及其对疗效判断的应用[J]. 中国卫生检验杂志, 2020, 30(4): 469.
[4] JAFARI D, MOUSAVI MJ, KESHAVARZ SHAHBAZ S, et al. E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy[J]. Clin Exp Immunol, 2021, 204(1): 14. doi: 10.1111/cei.13560
[5] EBNER P, VERSTEEG GA, IKEDA F. Ubiquitin enzymes in the regulation of immune responses[J]. Crit Rev Biochem Mol Biol, 2017, 52(4): 425. doi: 10.1080/10409238.2017.1325829
[6] TANG R, LANGDON WY, ZHANG J. Regulation of immune responses by E3 ubiquitin ligase Cbl-b[J]. Cell Immunol, 2019, 340: 103878. doi: 10.1016/j.cellimm.2018.11.002
[7] ROMO TENA J, RAJME LOPEZ S, APARICIO VERA L, et al. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus[J]. Clin Exp Immunol, 2018, 191(1): 42.
[8] 方苏, 郭翔宇, 冷秀秀, 等. 多发性骨髓瘤患者外周血单个核细胞c-Cbl和Cbl-b基因表达下调[J]. 细胞与分子免疫学杂志, 2013, 29(8): 842.
[9] FUJIWARA M, ANSTADT EJ, KHANNA KM, et al. Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720[J]. Clin Immunol, 2015, 158(1): 103. doi: 10.1016/j.clim.2015.03.018
[10] 陈丽娜, 宁建英. 免疫性血小板减少症(ITP)患儿血小板参数及骨髓象的临床意义[J]. 吉林医学, 2021, 42(4): 832.
[11] 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J]. 中华血液学杂志, 2020, 41(8): 617.
[12] 吴伯艳, 吴东升, 练成宇, 等. 原发免疫性血小板减少症患者外周血淋巴细胞亚群、NKT细胞及Th1/Th2细胞因子的变化及意义[J]. 广东医科大学学报, 2022, 40(5): 549.
[13] 张彤晖, 胡有天, 吴方. Cbl-b蛋白的重组表达、纯化和活性检测方法的建立[J]. 基因组学与应用生物学, 2019, 38(7): 2981.
[14] LI X, GONG L, GU H. Regulation of immune system development and function by Cbl-mediated ubiquitination[J]. Immunol Rev, 2019, 291(1): 123. doi: 10.1111/imr.12789
[15] NGUYEN TTT, WANG ZE, SHEN L, et al. Cbl-b deficiency prevents functional but not phenotypic T cell anergy[J]. J Exp Med, 2021, 218(7): e20202477.
[16] HAN S, LIU ZQ, CHUNG DC, et al. Overproduction of IFNγ by Cbl-b-Deficient CD8+ T cells provides resistance against regulatory T cells and induces potent antitumor immunity[J]. Cancer Immunol Res, 2022, 10(4): 437.
[17] SONG J, ANDERSON W, HU A, et al. CBLB deficiency in human CD4+T cells results in resistance to T regulatory suppression through multiple mechanisms[J]. J Immunol, 2022, 209(7): 1260.
[18] 邓淳, 肖斌, 李纬玮, 等. 乳腺癌组织CBL-B蛋白表达与生物学行为和预后关系[J]. 中华肿瘤防治杂志, 2020, 27(4): 276.
[19] LI C, DONG Q, CHE X, et al. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma[J]. BMC Cancer, 2018, 18(1): 681.
[20] LI P, LIU HL, ZHANG ZQ, et al. Single nucleotide polymorphisms of casitas B-lineage lymphoma proto-oncogene-b predict outcomes of patients with advanced non-small cell lung cancer after first-line platinum based doublet chemotherapy[J]. J Thorac Dis, 2018, 10(3): 1635.
[21] 钟隽, 陈少华, 郁志, 等. ITP中T细胞活化信号分子c-Cbl和Cbl-b的表达变化[J]. 暨南大学学报(自然科学与医学版), 2016, 37(6): 472.
[22] 刘五香, 袁相波, 孙红. 血小板参数动态检测及分析在ITP患儿病情评估中的应用价值[J]. 河南外科学杂志, 2022, 28(4): 149.
[23] 张加勤, 侯香华, 洪强, 等. MPV、PDW联合PAIg对急性原发免疫性血小板减少症患儿骨髓巨核细胞成熟障碍诊断价值的研究[J]. 中国实验血液学杂志, 2019(6): 1949.
[24] WANG W, TAO S, ZHANG X, et al. The value of combined detection of megakaryocyte and platelet parameters for the diagnosis of primary immune thrombocytopenia[J]. Clin Appl Thromb Hemost, 2022, 28: 10760296221106779.
[25] 黄舜明. 全自动血液分析仪血小板参数检测对血小板减少性疾病的早期诊断价值[J]. 白求恩医学杂志, 2017, 15(1): 111.
[26] BUITRAGO L, TSYGANKOV A, SANJAY A, et al. Cbl proteins in platelet activation[J]. Platelets, 2013, 24(6): 419.